It’s time for the big guns to come out at the $34 billion Sigma Healthcare amid a wave of selling triggered by Chemist Warehouse’s reverse listing.
Sources told this column Australia’s biggest investment banks – galvanised by the prospect of another lean year on the fees front – are throwing everything they’ve got at wooing Chemist Warehouse co-founders Jack Gance, Sam Gance and Mario Verrocchi, ahead of the first leg of expiries on escrows or selling restrictions.
Loading...
Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones. Email Sarah at sarah.thompson@afr.com
Emma Rapaport is a co-editor of the Street Talk column. Prior to that, she was a markets reporter at The Australian Financial Review. Connect with Emma on Twitter. Email Emma at emma.rapaport@afr.com